Publicaciones (294) Publicaciones de LEOPOLDO PÉREZ DE ISLA

2024

  1. Age- and sex-based heterogeneity in coronary artery plaque presence and burden in familial hypercholesterolemia: A multi-national study

    American Journal of Preventive Cardiology, Vol. 17

  2. Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study

    Circulation. Cardiovascular imaging, Vol. 17, Núm. 1, pp. e016206

  3. Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients

    Atherosclerosis, Vol. 392

  4. Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 34, Núm. 1, pp. 90-97

2023

  1. Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study

    Circulation, Vol. 147, Núm. 19, pp. 1436-1443

  2. Cardiovascular Risk Scores: Great Tools… When Used by Good Physicians

    Revista Argentina de Cardiologia

  3. Cardiovascular Risk Scores: Great Tools… When Used by Good Physicians

    Revista Argentina de Cardiologia

  4. Coronary microvascular dysfunction is associated with impaired cognitive function: the Cerebral-Coronary Connection study (C3 study)

    European heart journal, Vol. 44, Núm. 2, pp. 113-125

  5. Icosapent ethyl in reducing residual risk. New evidence

    Revista Espanola de Cardiologia Suplementos, Vol. 23, Núm. SA, pp. 15-19

  6. Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

    Neurology and Therapy, Vol. 12, Núm. 5, pp. 1759-1775

  7. Intracoronary thrombus assessment with cardiac computed tomography angiography in a deferred stenting strategy: The MATURE prospective study (MSCT to Assess ThrombUs REsolution)

    Coronary Artery Disease, Vol. 34, Núm. 3, pp. 167-176

  8. Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain

    Enfermedades Infecciosas y Microbiologia Clinica

  9. Persistence with long-term PCSK9 inhibitor treatment and its effectiveness in familial hypercholesterolaemia: data from the SAFEHEART study

    European journal of preventive cardiology, Vol. 30, Núm. 4, pp. 320-328

  10. Relevance of subclinical right ventricular dysfunction measured by feature-tracking cardiac magnetic resonance in non-ischemic dilated cardiomyopathy

    BMC Cardiovascular Disorders, Vol. 23, Núm. 1

  11. Response by Pérez de Isla et al to Letter Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study"

    Circulation

2022

  1. A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort

    European Journal of Preventive Cardiology, Vol. 29, Núm. 5, pp. 795-801

  2. Guía práctica sobre el diagnóstico y tratamiento de la hipertensión arterial en España, 2022. Sociedad Española de Hipertensión - Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA)

    Hipertensión y riesgo vascular, Vol. 39, Núm. 4, pp. 174-194

  3. Impact of previous cardiac function status assessed by echocardiography on the outcome of COVID-19

    Scientific Reports, Vol. 12, Núm. 1

  4. Is it Time for Single-Pill Combinations in Dyslipidemia?

    American Journal of Cardiovascular Drugs, Vol. 22, Núm. 3, pp. 239-249

  5. Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients

    Journal of Clinical Lipidology, Vol. 16, Núm. 5, pp. 733-736